biomedicina slovenica


re="Farm Vestn" : 338-437

  1. Wirth M; Bogner E; Harant C; Langoth N; Gabor F
    Wheat germ agglutinin-mediated drug delivery: gastrointestinal fate and transport studies using Caco-2 monolayers
    1999
  2. Realdon N; Bettero A; Ragazzi E
    A new approach to the quality control of medical devices
    1999
  3. Realdon N; Marcazzan M; Ragazzi E
    Quality control of medical devices: the problem of urethral catheters
    1999
  4. Homšek Irena; Jovanović Milica
    Effect of tablet processing on dissolution rate of nitrendipine
    1999
  5. Gomez-Carracedo A; Martinez-Pacheco R; Souto C; Concheiro A; Gomez-Amoza JL
    Compaction and drug release properties of freeze dried and oven dried carbopol 934p-microcrystalline cellulose pellets
    1999
  6. Perissutti B; Newton JM; Podczeck F; Rubessa F
    Extrudates of carbamazepine and PEG 4000 in a ram extruder
    1999
  7. Trajković-Jolevska S; Kocova K; Ugrinova L; Dimitrovska A
    Application of derivative UV-spectrophotometric method in the dissolution test of fluconazol capsules
    1999
  8. Shprakh Z; Obortova N; Kikotj B
    Investigations of antitumor preparation chlogiphen aqueous solutions stability
    1999
  9. Vehabović Midhat; Hadžović Sabira; Dizdarević Aida; Heračić Ediba
    Stability study for sulfamethoxazolum + trimethoprimum suspension
    1999
  10. Rehula Milan
    Effect of active fillers on the properties of polymeric silicone matrices
    1999
  11. Echezarreta-Lopez M; Torres-Labandeira JJ; Castineiras-Seijo L; Vila-Jato JL
    Effect of water-soluble polymers on the aqueous solutility and complexing abilities of bropirimine with dimethyl-beta- and hydroxypropyl-beta-cyclodextrin
    1999
  12. Anghelescu-Dogaru Adina Graziella; Chitanu Gabrielle Charlotte; Dumistracel Irina; Carpov A; Bulacovschi V
    Maleic polymers with amidic side units as additives for pharmaceutical formulations
    1999
  13. Marschuetz MK; Clausen AE; Bernkop-Schnuerch A
    Development of a CMC-inhibitor conjugate protecting insulin from enzymatic attack in an artificial intestinal fluid
    1999
  14. Bernkop-Schnuerch A; Hoffer M; Kirchmayer R; Kratzel M
    A drug delivery system with protective effect towards pepsinic degradation - development, synthesis and in vitro evaluation
    1999
  15. Laznickova Alice; Laznicek Milan
    Protein binding of some 99mTc-radiopharmaceuticals
    1999
  16. Laznickova Alice; Laznicek M; Maecke HR
    Preparation of radiolabelled receptor-specific peptides for cancer diagnosis and treatment
    1999
  17. Berko Szilvia; Regdon Geza Jr; Eros I
    Influencing drug release from rectal suppositories containing ethacrynic acid
    1999
  18. Eros I; Sourbayi M; Csoka I; Koever T; Cserne A
    Effect of composition and rheological properties of suspensions on their drug release
    1999
  19. Clausen AE; Marschuetz MK; Steininger S; Bernkop-Schnuerch A
    Method to control the stability of matrix tablets based on thiolated polycarbophil
    1999
  20. Fredro-Kumbaradzi E; Mihajlovska H; Goracinova K; Mladenovska K; Glavas M
    Preparation and evaluation of lidocaine hydrochloride loaded liposomes
    1999
  21. Goracinova K; Makraduli L; Fredro-Kumbaradzi E; Glavas M; Mladenovska K
    Povidone-iodine liposomes - preparation and characterization
    1999
  22. Selek H; Ponchel G; Kas S; Hincal AA
    Preparation and enzymatic degeneration of the cross-linked degradable starch microspheres by pancreatin
    1999
  23. Filipović-Grčić J; Voinovich D; Moneghini M; Bećirević-Laćan M; Magarotto L; Jelšenjak I
    Chitosan microspheres of hydrocortisone and its inclusion complex with hydroxypropyl-beta-cyclodextrin: physicochemical characterization and in vivo absorption of the drug
    1999
  24. Kasa P Jr; Pintye-Hodi K; Szabo-Revesz P
    Study of texture of pellets prepared with a centrifugal-granulator with the use of different binder materials
    1999
  25. Regdon G Jr; Kasa P Jr; Pintye-Hodi K; Szabo-Revesz P
    Preparation of tablets from ambroxol hydrochloride pellets
    1999
  26. Jachowicz R; Pieszcek B; Kluczykowska B; Maciejewska A
    Ternary solid dispersion of ketoprofen in pellets
    1999
  27. Remunan-Lopez C; Portero A; Vila-Jato JL; Alonso MJ
    Chitosan devices for buccal administration of insulin
    1999
  28. Valenta Claudia; Wanka Marlies; Heidlas Juergen
    Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug
    1999
  29. Maggi L; Bruni R; Torre MI; Conte U
    Influence of inspiratory flow rate and storage conditions on dosage precision and disaggregation efficiency of a new multidose dry powder inhaler
    1999
  30. Oborotova N; Kikotj B; Polozkova A; Ignatyeva E; Budko A; Gatinskaya L; Zimakova N; Orlova O
    Pharmaceutical study of mitoxantrone new drug formulation - bisantrone
    1999
  31. Truplova E; Kralova J; Matušova D
    Preformulation studies on solid dispersions of lipophilic drug
    1999
  32. Ceschel GC; Maffei P
    Optimization of the permeability of nimesulide from a topical gel formulation using the enhanver fomblin and acting on the pH of the vehicle
    1999
  33. Reich HB
    Kollicoat SR 30 D and Kollidon SR
    1999
  34. Skerjanec A; Sandler A; Green L; Marder P; Kuan S; Chaudhary A; Slapak C
    A phase I dose-escalating trial of LY335979, a potent multidrug-resistance modulator
    1999
  35. Laznicek Milan
    Prediction of pharmacokinetic parameters from physicochemical characteristics in structurally similar drugs
    1999
  36. Arshady Reza
    Manufacturing methodology of microcapsules
    1999
  37. Eros I; Csoka I; Koever T; Cserne A; Csanyi E
    Relationship between rheological and biopharmaceutical characteristics of disperse and coherent dosage forms
    1999
  38. Eichler Klaus; Ulrich Maik
    New technique for the continuous production of microspheres from liquid formulations
    1999
  39. Sancin P; Albertini B; Cavallari C; Cini M; Rodriguez L
    Wet granulation of pharmaceutical powders by means of steam
    1999
  40. Schmidt Peter C
    Pulmonary drug delivery from a tablet: development of a new device
    1999
  41. Gorenjak Maksimiljan
    Uporaba plinske kromatografije z masno spektrometrijo v klinični toksikologiji
    2000
  42. diMagno T; Arter T; Chambers D; Graby C; Hassett J; Krauza C; Mauck L; Novick R; Pihel K; Shaver D
    A multiple center evaluation of the VITROS phenobarbital assay for VITROS chemistry systems
    2000
  43. Kuštrin A; McCusker CA; Lamont JV; Fitzgerald SP
    Effects of ageing and human disease on levels of total antioxidant status
    2000
  44. Kuštrin A; McCusker MD; Johnston HE; Lamont JV; Campbell JJ; Fitzgerald SP
    Rapid measurement of C-reactive protein (SRP) using a new ultra-sensitive microparticle-enhanced immunoturbidimetric assay
    2000
  45. Čučnik Saša; Božič Borut; Kveder Tanja; Rozman Blaž
    Antifosfolipidna protitelesa in možganska kap pri mladih ženskah brez sistemskih avtoimunskih bolezni
    2000
  46. Zorn B; Virant-Klun I; Meden-Vrtovec H; Briški-Sešek A; Kolbezen-Simoniti M
    Semen granulocyte elastase: its relevance for the diagnosis and prognosis of silent genital tract inflammation
    2000
  47. Zorn B; Virant-Klun I; Meden-Vrtovec H; Kolbezen-Simoniti M
    Sperm reactive oxygen species production is linked to high percentage of single-stranded sperm DNA and affects negatively fertilization in classical in vitro fertilization, but not in ICSI
    2000
  48. Krsnik M; Prezelj M
    Določevanje katalaze v eritrocitih
    2000
  49. Božič M; Teran N; Kunej T; Peterlin B; Stegnar M
    Ali izboljšava preiskave na neodzivnost aktiviranega proteina C zmanjšuje potrebo po analizi DNA?
    2000
  50. Plazar Nadja; Marušič Dorjan
    Vrednosti c troponina I, kreatin kinaze, kreatin kinaze izoencima MB in mioglobina v serumu po transtorakalni direktni elektrokardiokonverziji
    2000
  51. Terčič Dunja
    Analiza sinovialne tekočine
    2000
  52. Trebušak K; Repič-Lampret B; Kržišnik C; Battelino T
    Klinična genetika avtoimunskega poliglandularnega sindroma tip 1 (APS-1)
    2000
  53. Gartner M; Avberšek-Lužnik I
    Totalni antioksidantni status pri dializnih in sladkornih bolnikih
    2000
  54. Vogler A; Meden-Vrtovec H; Osredkar J
    IGF-1 v serumu in foliklovi tekočini pri bolnicah s slabim odzivom na stimulacijo ovulacije v postopku zunajtelesne oploditve
    2000
  55. Krivec Štefka; Malešič Ivan; Voga Gorazd
    Biokemični označevalci pri bolnikih z akutnim koronarnim sindromom
    2000
  56. Mlinar Barbara; Marc Janja; Lukač-Bajalo Jana; Karas Nataša; Battelino Tadej
    A prevalence of N314D mutation of galactose-1-phosphate uridyltransferase gene in Slovenian population
    2000
  57. Naumov A; Briški A; Vrtovec M; Čolić R; Osredkar J
    Koncentracija kroma v laseh - pokazatelj obremenjenosti organizma s kromovimi spojinami
    2000
  58. Černe Darko; Skitek Milan
    Pomen srčnega troponina I v diagnostiki nekroze miokarda
    2000
  59. Prezelj Marija; Bratož Saša
    Osnovni in splošni izrazi s področja meroslovja v klinični kemiji
    2000
  60. Čučnik Saša; Ambrožič Aleš; Kveder Tanja; Skitek Milan; Božič Borut
    Vrednotenje analizne metode s pomočjo biološke variabilnosti
    2000
  61. Božič Borut
    Zagotavljanje kakovosti v diagnostičnih laboratorijih in evropski pravni red
    2000
  62. Piskar Majda; Trampuš-Bakija Alenka
    Določitev orientacijskih referenčnih vrednosti za retikulocite in nove retikulocitne parametre na hematološkem analizatorju Beckman Coulter GEN-S
    2000
  63. Krsnik M; Briški A; Prezelj M
    Ovrednotenje reagentov proizvajalca Olympus na analizatorju Olympus AU600
    2000
  64. Skitek Milan; Piskar Majda; Černe Darko; Božič Borut
    Quality planning through validation of biology goals in haemocytometry
    2000
  65. Hoyle NR; Ebert C
    Elecsys beta CrossLaps/serum - an international technical and clinical evaluation
    2000
  66. Fliser E; Gorenjak M
    Evaluation of Dade Behring dimension RXL
    2000
  67. Marc Janja; Preželj Janez; Komel Radovan; Kocijančič Andreja
    Polimorfizem gena za VDR in biokemični kazalci presnove kosti pri zdravljenju osteoporoze z bisfosfonati
    2000
  68. Avberšek-Lužnik I; Malešič I
    Kostna alkalna fosfataza pri ženskah po menopavzi
    2000
  69. Bitenc Darja; Marc Janja; Lukač-Bajalo Jana
    SSCP analiza kodona 325 gena za estrogenski receptor alfa
    2000
  70. Shihabi Z; Bucksa J; Lott J; Sheehan M; Luke K; Wallace J; Sommer R; Pugia M; Orn A
    Clinical evaluation of a new strip test for proteinuria on Clinitek urinanalysis systems
    2000
  71. Slavec B; Mencin D
    Primerjava rezultatov urinskih presejalnih testov dveh proizvajalcev na Clinitek-100
    2000
  72. Prezelj Marija; Zorec-Karlovšek Majda
    % CDT - trasferin z zmanjšanim deležem ogljikovih hidratov v diagnostiki škodljive rabe alkohola
    2000
  73. Sedmak M; Zupančič M; Logar-Car G
    Vloga IgA-protiteles proti tkivni transglutaminazi v stopenjski diagnostiki celiakije
    2000
  74. Logar-Car G; Sedmak M; Zupančič M; Orel R; Jereb J; Cerar A
    Določanje IgA protiteles proti tkivni transglutaminazi in diagnosticiranje različnih oblik celiakije pri ožjih družinskih članih bolnikov s celiakijo
    2000
  75. Gobec Lidija; Krivec Štefka
    Hitri semikvantitativni test za določanje prokalcitonina v serumu
    2000
  76. Geršak Ksenija; Novak-Antolič Živa; Osredkar Joško
    Učinkovitost presejalnega trojnega hormonskega testa za trisomijo 21 v Sloveniji
    2000
  77. Zupančič M; Krsnik M
    Primerjava metod določanja protijedrnih protiteles (ANA) z indirektno imunofluorescenco (ANA HEp-2) in imuno-encimsko metodo (INNO-LIA ANA)
    2000
  78. Sedmak B; Osredkar J; Tršinar B
    Diagnostična vrednost deleža proste oblike PSA pri diagnostiki karcinoma prostate
    2000
  79. Babič Katica; Černe Darko; Osredkar Joško
    Prokalcitonin v programu urgentnih laboratorijskih preiskav
    2000
  80. Furlan Danijela
    Diagnostični laboratorij v regijski bolnišnici
    2000
  81. Gorenjak Maksimiljan
    Informacijski sistemi v laboratorijih
    2000
  82. Bratož Saša
    Organizacija klinično kemijskih laboratorijev v Sloveniji kot osnova za kakovost
    2000
  83. Prezelj Marija
    Sistem vodenja kakovosti v kliničnem laboratoriju
    2000
  84. Williams David L
    Quality management and accreditation in clinical laboratories
    2000
  85. Palicka Vladimir; Friedecky Bedrich; Vavrova Jaroslava; Zivny Pavel
    Organisation, management and education as tools for accreditation of clinical laboratories
    2000
  86. Arko Barbara
    Polimorfizmi genov za estrogenska receptorja alfa in beta pri bolnicah z osteoporozo
    2000
  87. Avberšek-Lužnik Ivica
    Serumske koncentracije osteokalcina pri ženskah po menopavzi
    2000
  88. Malešič Ivan
    Kostna alkalna fosfataza kot označevalec remodelacije kosti in uspešnosti terapije
    2000
  89. Palicka Vladimir; Friedecky Bedrich; Zivny Pavel; Rehorkova Pavla
    Metabolism of bone cells - local factors and a mirror in laboratory results
    2000
  90. Marc Janja
    Biokemični in genetični kazalci osteoporoze
    2000
  91. Kocijančič Andreja
    Osteoporoza
    2000
  92. Stegnar Mojca
    D-dimeri in njihova uporabnost pri izključevanju venske tromboze
    2000
  93. Zadro Renata; Coen Desiree
    Laboratory diagnosis of lupus anticoagulants: screening and confirmatory test
    2000
  94. Kobe Jasna Modrica
    Hitri presejalni testi v laboratorijski diagnostiki infekcijskih bolezni
    2000
  95. Kveder Tanja
    Stopenjska imunoserološka diagnostika sistemskih vezivnotkivnih bolezni
    2000
  96. Božič Borut
    Imunokemijske metode v klinični kemiji - presejalni ali potrditveni testi?
    2000
  97. Lukač-Bajalo Jana
    Presejalni testi za odkrivanje vrojenih presnovnih motenj
    2000
  98. Siest Gerard
    Screening and prediction in supposed healthy families. The experiences of the Centre of preventive medicine, Nancy, France
    2000
  99. Osredkar Joško
    Screening test in establishing a diagnosis. Screening for Down's syndrome
    2000
  100. Osredkar Joško
    Beseda gostujočega urednika
    [Guest editor's preface]
    2000

   1 38 138 238 338 438 538 638 738 838  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko